Kingmed Diagnostics was among the investors in the $44.7m round, the proceeds of which will fund development of Creative Biosciences' cancer diagnostics kits.

Sidewalk Labs spinoff Cityblock raised the cash in an EmblemHealth and Echo Health Ventures-backed round that took its overall funding above $85m.

Cambridge-founded chemicals products maker Aqdot has welcomed the return of IP Group and Parkwalk Advisors in its latest round, taking its funding total to $16.5m.

FujiFilm-backed genetic disorder drug developer EdiGene has secured $14.3m from investors including SBI Investment, SMBC Capital and Mizuho Capital.

UTokyo's Innovation Platform joined subsidiaries of SBI, Sumitomo Mitsui and Mizuho Bank to help double genetic disorder treatment developer EdiGene's funding.

Varian Medical Systems co-led the series B round, which will fund the development of ABK Biomedical's embolic therapies.

Varian led a round for the targeted cancer drug developer that included existing investors such as Facit and Johnson & Johnson.

NTT Comware has agreed to take part in a series B round the corporate-backed orchestration software producer intends to close at $20m.

NavInfo led a series B round that increased the advanced driver-assistance system developer's funding to $20m over the past six months.

The cybersecurity software provider landed $20.6m in the Paladin Capital-led round, which featured Dell Technologies Capital and MassMutual Ventures.